Compare SINT & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SINT | VVOS |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 9.7M |
| IPO Year | 2007 | 2020 |
| Metric | SINT | VVOS |
|---|---|---|
| Price | $1.92 | $0.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $11.00 | $2.75 |
| AVG Volume (30 Days) | 46.2K | ★ 3.7M |
| Earning Date | 05-13-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.45 | 6.76 |
| EPS | N/A | ★ N/A |
| Revenue | $1,018,000.00 | ★ $17,443,000.00 |
| Revenue This Year | $30.26 | $69.66 |
| Revenue Next Year | $413.20 | $48.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $1.85 | $0.38 |
| 52 Week High | $6.78 | $7.40 |
| Indicator | SINT | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 40.43 | 36.65 |
| Support Level | $1.93 | N/A |
| Resistance Level | $2.98 | $0.76 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 27.59 | 13.57 |
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.